NCT00064779View on ClinicalTrials.gov

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

July 31, 2007

Conditions
Malignant GliomaGlioblastoma MultiformeAnaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Oligoastrocytoma
Interventions
DRUG

IL13-PE38QQR

PROCEDURE

targeted fusion protein therapy

PROCEDURE

surgery

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY

NCT00064779 - Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma | Biotech Hunter | Biotech Hunter